Akçali Cenk, Guven Ebru Homurlu, Kirtak Necmettin, Inaloz H Serhat, Ozgoztasi Orhan, Guvenc Ulas
Department of Dermatology, Faculty of Medicine, University of Gaziantep, Gaziantep, Turkey
Department of Dermatology, Avukat Cengiz Gokcek State Hospital, Gaziantep, Turkey.
J Int Med Res. 2014 Oct;42(5):1118-22. doi: 10.1177/0300060514539280. Epub 2014 Aug 20.
A prospective, randomized clinical study to compare the short-term effects of cyclosporin and acitretin on psoriasis severity, and serum interleukin (IL)-2 and tumour necrosis factor (TNF)-α concentrations.
Patients with moderate-to-severe plaque-type psoriasis were randomly assigned to receive either 3 mg/kg per day cyclosporine or 0.3-0.5 mg/kg per day acitretin for 8 weeks. Disease severity (psoriasis area severity index [PASI] score) and serum IL-2 and TNF-α concentrations were determined before and after treatment.
PASI scores and serum IL-2 and TNF-α concentrations were significantly decreased after treatment with either cyclosporine (n = 21) or acitretin (n = 25). There were no statistically significant between-group differences in any parameter.
Acitretin and cyclosporine are equally effective in the treatment of moderate-to-severe plaque-type psoriasis.
一项前瞻性随机临床研究,比较环孢素和阿维A对银屑病严重程度以及血清白细胞介素(IL)-2和肿瘤坏死因子(TNF)-α浓度的短期影响。
中重度斑块型银屑病患者被随机分配,接受每日3mg/kg环孢素或每日0.3 - 0.5mg/kg阿维A治疗8周。在治疗前后测定疾病严重程度(银屑病面积严重指数[PASI]评分)以及血清IL-2和TNF-α浓度。
环孢素组(n = 21)和阿维A组(n = 25)治疗后PASI评分以及血清IL-2和TNF-α浓度均显著降低。各参数在组间均无统计学显著差异。
阿维A和环孢素在治疗中重度斑块型银屑病方面同样有效。